Two Sigma Securities’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-15,656
| Closed | -$2.91M | – | 1331 |
|
|
2025
Q2 | $2.91M | Buy |
+15,656
| New | +$2.91M | 0.36% | 46 |
|
|
2025
Q1 | – | Sell |
-1,769
| Closed | -$314K | – | 1401 |
|
|
2024
Q4 | $314K | Buy |
+1,769
| New | +$325K | 0.04% | 612 |
|
|
2023
Q4 | – | Sell |
-33,786
| Closed | -$4.93M | – | 2966 |
|
|
2023
Q3 | $5.04M | Buy |
33,786
+31,539
| +1,404% | +$4.63M | 0.05% | 360 |
|
|
2023
Q2 | $303K | Sell |
2,247
-1,096
| -33% | -$161K | ﹤0.01% | 1866 |
|
|
2023
Q1 | $533K | Buy |
+3,343
| New | +$511K | 0.01% | 1223 |
|
|
2022
Q4 | – | Sell |
-6,031
| Closed | -$925K | – | 2520 |
|
|
2022
Q3 | $809K | Buy |
6,031
+3,470
| +135% | +$498K | 0.02% | 766 |
|
|
2022
Q2 | $392K | Sell |
2,561
-6,521
| -72% | -$996K | 0.01% | 1082 |
|
|
2022
Q1 | $1.47M | Buy |
9,082
+6,029
| +197% | +$876K | 0.05% | 451 |
|
|
2021
Q4 | $413K | Buy |
+3,053
| New | +$361K | 0.02% | 631 |
|
|
2021
Q3 | – | Sell |
-8,241
| Closed | -$942K | – | 1501 |
|
|
2021
Q2 | $928K | Buy |
+8,241
| New | +$928K | 0.03% | 430 |
|
|
2019
Q4 | – | Sell |
-3,936
| Closed | -$327K | – | 2292 |
|
|
2019
Q3 | $298K | Sell |
3,936
-14,368
| -78% | -$985K | ﹤0.01% | 1559 |
|
|
2019
Q2 | $1.33M | Buy |
+18,304
| New | +$1.44M | 0.01% | 617 |
|
|
2018
Q4 | – | Sell |
-7,792
| Closed | -$685K | – | 2083 |
|
|
2018
Q3 | $737K | Sell |
7,792
-19,483
| -71% | -$1.85M | ﹤0.01% | 1184 |
|
|
2018
Q2 | $2.53M | Sell |
27,275
-30,689
| -53% | -$3M | 0.01% | 786 |
|
|
2018
Q1 | $5.49M | Buy |
57,964
+53,648
| +1,243% | +$5.89M | 0.03% | 443 |
|
|
2017
Q4 | $417K | Buy |
+4,316
| New | +$407K | 0.01% | 797 |
|
|
2017
Q3 | – | Sell |
-12,966
| Closed | -$940K | – | 898 |
|
|
2017
Q2 | $940K | Sell |
12,966
-14,661
| -53% | -$986K | 0.18% | 103 |
|
|
2017
Q1 | $1.8M | Buy |
27,627
+23,737
| +610% | +$1.49M | 0.35% | 47 |
|
|
2016
Q4 | $244K | Sell |
3,890
-11,214
| -74% | -$685K | 0.08% | 325 |
|
|
2016
Q3 | $953K | Buy |
+15,104
| New | +$978K | 0.32% | 68 |
|
|
2015
Q4 | – | Sell |
-4,638
| Closed | -$252K | – | 266 |
|
|
2015
Q3 | $252K | Buy |
+4,638
| New | +$302K | 0.4% | 95 |
|
Other funds holding ABBV
Two Sigma Securities's ABBV Position: Q3 2025 in Review
Two Sigma Securities sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 15,656 shares — an estimated $2.91M sold.
Two Sigma Securities first reported a position in ABBV in Q3 2015 and held it in 21 quarters. The position peaked at $5.49M in Q1 2018. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Two Sigma Securities reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
- Two Sigma Securities sold 15,656 AbbVie shares in Q3 2025, an estimated $2.91M.
- Two Sigma Securities first reported a position in AbbVie in Q3 2015 and held it in 21 quarters.
- Two Sigma Securities's AbbVie position peaked at $5.49M in Q1 2018.
- 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.